Squarepoint Ops LLC Buys 109,007 Shares of Encompass Health Co. (NYSE:EHC)

Squarepoint Ops LLC boosted its position in shares of Encompass Health Co. (NYSE:EHC) by 599.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 127,204 shares of the company’s stock after buying an additional 109,007 shares during the quarter. Squarepoint Ops LLC’s holdings in Encompass Health were worth $11,747,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB raised its position in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares during the last quarter. Colonial Trust Co SC acquired a new stake in Encompass Health in the fourth quarter worth about $29,000. Transce3nd LLC bought a new stake in Encompass Health during the 4th quarter worth about $40,000. CBIZ Investment Advisory Services LLC lifted its position in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after purchasing an additional 127 shares during the period. Finally, V Square Quantitative Management LLC boosted its stake in shares of Encompass Health by 43.8% in the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock valued at $54,000 after purchasing an additional 177 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Stock Down 1.1%

NYSE:EHC opened at $118.49 on Friday. Encompass Health Co. has a 1 year low of $82.74 and a 1 year high of $121.96. The stock has a 50-day moving average price of $107.42 and a two-hundred day moving average price of $101.30. The stock has a market cap of $11.94 billion, a price-to-earnings ratio of 26.57, a PEG ratio of 2.31 and a beta of 0.91. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Encompass Health’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.12 EPS. As a group, equities analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date is Tuesday, July 1st. Encompass Health’s dividend payout ratio (DPR) is presently 14.05%.

Insider Buying and Selling at Encompass Health

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the sale, the insider now directly owns 11,958 shares in the company, valued at $1,394,422.38. This trade represents a 26.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Mark J. Tarr sold 118,384 shares of the stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the transaction, the chief executive officer now owns 527,070 shares of the company’s stock, valued at $64,054,817.10. The trade was a 18.34% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 132,663 shares of company stock valued at $16,034,082 in the last 90 days. 2.00% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on EHC shares. Truist Financial restated a “buy” rating and issued a $135.00 price objective (up from $116.00) on shares of Encompass Health in a report on Monday, April 28th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. KeyCorp lifted their price objective on Encompass Health from $120.00 to $122.00 and gave the stock an “overweight” rating in a research note on Friday, April 25th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, May 11th. Finally, Royal Bank of Canada boosted their target price on Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a research report on Monday, April 28th. Nine equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $120.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.